Presently, I am working as a Senior Pharmacovigilance Associate with NCC- PvPI at Indian Pharmacopoeia Commission. I work on Vigiflow software which is monitored by WHO- Uppsala Monitoring Centre, Sweden. Basically I am looking after the ADR reporting from various National Health Programmes like National Vector Borne Disease Control Programme (NVBDCP), National AIDS Control Organisation (NACO), Adverse Event Following Immunization (AEFI), and Revised National Tuberculosis Control Programme (RNTCP).
I also have experience on Argus & MedDRA at Wipro BPS HLS (Healthcare & Life Sciences Division) as Pharmacovigilance Officer.
I have also worked as an Assistant Professor in M.M. University....
Datos de contacto
Etiquetas
proinsulinc-peptideinsulinvagus nerve stimulationuse of vns in epilepsyvnsvns.vijitvns in epilepsycruel trialskarl brandt in nuremberg codedoctor's trialethical issues in clinical trialsclinical trialthe nuremberg codeclinical trial ethical considerationsclinical trial ethicsneuremberg's code.vijitethicsfactors affecting tdm.vijittdm factors.vijitfactors affecting tdmfactors affecting therapeutic drug monitoringtdmthings need to be consider in therapeutic drug monobcessive compulsive therapyhow to keep yourself calmexposure and response prevention.vijitmental relaxation techniqueserpapplied relaxationcognitive behavioural therapycbt.vijitvaccinesvaccine associated risks studiesfda vaccine safetyfdavaccine licensing processadverse events following immunizationvaccine manufacturing licensevaccine safetyvaersnationalcdcvaccine safety datalinkdosing of carbamazepine in paediatrics and childremechanism of action of carbamazepineside effects of carbamazepinecarbamazepinepneumonia treatmentpneumonia
Presently, I am working as a Senior Pharmacovigilance Associate with NCC- PvPI at Indian Pharmacopoeia Commission. I work on Vigiflow software which is monitored by WHO- Uppsala Monitoring Centre, Sweden. Basically I am looking after the ADR reporting from various National Health Programmes like National Vector Borne Disease Control Programme (NVBDCP), National AIDS Control Organisation (NACO), Adverse Event Following Immunization (AEFI), and Revised National Tuberculosis Control Programme (RNTCP).
I also have experience on Argus & MedDRA at Wipro BPS HLS (Healthcare & Life Sciences Division) as Pharmacovigilance Officer.
I have also worked as an Assistant Professor in M.M. University....
Etiquetas
proinsulinc-peptideinsulinvagus nerve stimulationuse of vns in epilepsyvnsvns.vijitvns in epilepsycruel trialskarl brandt in nuremberg codedoctor's trialethical issues in clinical trialsclinical trialthe nuremberg codeclinical trial ethical considerationsclinical trial ethicsneuremberg's code.vijitethicsfactors affecting tdm.vijittdm factors.vijitfactors affecting tdmfactors affecting therapeutic drug monitoringtdmthings need to be consider in therapeutic drug monobcessive compulsive therapyhow to keep yourself calmexposure and response prevention.vijitmental relaxation techniqueserpapplied relaxationcognitive behavioural therapycbt.vijitvaccinesvaccine associated risks studiesfda vaccine safetyfdavaccine licensing processadverse events following immunizationvaccine manufacturing licensevaccine safetyvaersnationalcdcvaccine safety datalinkdosing of carbamazepine in paediatrics and childremechanism of action of carbamazepineside effects of carbamazepinecarbamazepinepneumonia treatmentpneumonia
